Su‐Yu Chien

798 total citations
21 papers, 640 citations indexed

About

Su‐Yu Chien is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Su‐Yu Chien has authored 21 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Su‐Yu Chien's work include Natural product bioactivities and synthesis (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Su‐Yu Chien is often cited by papers focused on Natural product bioactivities and synthesis (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Su‐Yu Chien collaborates with scholars based in Taiwan, United States and Canada. Su‐Yu Chien's co-authors include Mu‐Kuan Chen, Ming‐Ju Hsieh, Dar‐Ren Chen, Shou‐Jen Kuo, Shun‐Fa Yang, Yi‐Ching Chuang, Yu‐Sheng Lo, Hui‐Yi Lin, Yi‐Ting Hsi and Jui‐Chieh Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Biomechanics.

In The Last Decade

Su‐Yu Chien

21 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su‐Yu Chien Taiwan 17 341 126 96 89 81 21 640
Qi Ren China 16 495 1.5× 140 1.1× 86 0.9× 98 1.1× 71 0.9× 65 937
Mianhua Wu China 14 436 1.3× 172 1.4× 99 1.0× 93 1.0× 66 0.8× 55 680
Yue-Yu Gu China 16 424 1.2× 117 0.9× 109 1.1× 54 0.6× 124 1.5× 20 839
Hsi‐Hsien Hsu Taiwan 12 309 0.9× 145 1.2× 177 1.8× 49 0.6× 46 0.6× 31 646
Fangtian Fan China 18 414 1.2× 192 1.5× 142 1.5× 63 0.7× 69 0.9× 44 760
Weili Min China 17 299 0.9× 110 0.9× 132 1.4× 63 0.7× 37 0.5× 26 591
Hongfei Tong China 18 392 1.1× 141 1.1× 133 1.4× 63 0.7× 42 0.5× 36 867
Qingdi Quentin Li China 18 393 1.2× 133 1.1× 183 1.9× 60 0.7× 37 0.5× 28 841
Hui He China 16 345 1.0× 98 0.8× 86 0.9× 48 0.5× 37 0.5× 30 670
Heran Wang China 11 388 1.1× 179 1.4× 187 1.9× 43 0.5× 84 1.0× 24 686

Countries citing papers authored by Su‐Yu Chien

Since Specialization
Citations

This map shows the geographic impact of Su‐Yu Chien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Yu Chien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Yu Chien more than expected).

Fields of papers citing papers by Su‐Yu Chien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Yu Chien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Yu Chien. The network helps show where Su‐Yu Chien may publish in the future.

Co-authorship network of co-authors of Su‐Yu Chien

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Yu Chien. A scholar is included among the top collaborators of Su‐Yu Chien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Yu Chien. Su‐Yu Chien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, D B, et al.. (2018). The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer. Annals of Surgical Oncology. 25(7). 2091–2097. 23 indexed citations
2.
Hsieh, Ming‐Ju, Jui‐Chieh Chen, Wei‐En Yang, et al.. (2017). Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-κB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition. Biochemical Pharmacology. 130. 10–20. 52 indexed citations
3.
Hsieh, Ming‐Ju, Chiao‐Wen Lin, Mu‐Kuan Chen, et al.. (2017). Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways. Scientific Reports. 7(1). 45039–45039. 47 indexed citations
4.
Lin, Heng‐Fu, Ming‐Ju Hsieh, Yi‐Ting Hsi, et al.. (2017). Celastrol-induced apoptosis in human nasopharyngeal carcinoma is associated with the activation of the death receptor and the mitochondrial pathway. Oncology Letters. 14(2). 1683–1690. 25 indexed citations
5.
Chien, Su‐Yu, Yi‐Ching Chuang, Yu‐Sheng Lo, et al.. (2017). Nimbolide induces apoptosis in human nasopharyngeal cancer cells. Environmental Toxicology. 32(8). 2085–2092. 25 indexed citations
6.
Hsieh, Ming‐Ju, Su‐Yu Chien, Jen‐Tsun Lin, Shun‐Fa Yang, & Mu‐Kuan Chen. (2016). Polyphyllin G induces apoptosis and autophagy cell death in human oral cancer cells. Phytomedicine. 23(13). 1545–1554. 44 indexed citations
7.
Chen, Jui‐Chieh, Ming‐Ju Hsieh, Chih‐Jung Chen, et al.. (2016). Polyphyllin G induce apoptosis and autophagy in human nasopharyngeal cancer cells by modulation of AKT and mitogen-activated protein kinase pathways in vitro and in vivo. Oncotarget. 7(43). 70276–70289. 45 indexed citations
8.
Chien, Su‐Yu, Ming‐Ju Hsieh, Chih‐Jung Chen, Shun‐Fa Yang, & Mu‐Kuan Chen. (2015). Nobiletin inhibits invasion and migration of human nasopharyngeal carcinoma cell lines by involving ERK1/2 and transcriptional inhibition of MMP-2. Expert Opinion on Therapeutic Targets. 19(3). 307–320. 48 indexed citations
9.
Hsieh, Ming‐Ju, Su‐Yu Chien, Ying‐Erh Chou, et al.. (2014). Hispolon from Phellinus linteus possesses mediate caspases activation and induces human nasopharyngeal carcinomas cells apoptosis through ERK1/2, JNK1/2 and p38 MAPK pathway. Phytomedicine. 21(12). 1746–1752. 43 indexed citations
10.
Lin, Che, et al.. (2013). Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women. World Journal of Surgical Oncology. 11(1). 139–139. 19 indexed citations
11.
Chen, Yao‐Li, Su‐Yu Chien, Shou‐Jen Kuo, et al.. (2013). Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro. Molecular Medicine Reports. 7(5). 1487–1493. 12 indexed citations
12.
Kuo, Shou‐Jen, Hui‐Yi Lin, Su‐Yu Chien, & Dar‐Ren Chen. (2013). SIRT1 suppresses breast cancer growth through downregulation of the Bcl-2 protein. Oncology Reports. 30(1). 125–130. 32 indexed citations
13.
Su, Chin‐Cheng, Su‐Yu Chien, Shou‐Jen Kuo, et al.. (2012). Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65. Molecular Medicine Reports. 5(4). 1019–1022. 28 indexed citations
14.
Chen, Shou‐Tung, et al.. (2011). Use of high‐dose nandrolone aggravates septic shock in a mouse model. The Kaohsiung Journal of Medical Sciences. 27(6). 222–229. 5 indexed citations
15.
Lai, Hung‐Wen, Chin‐Cheng Su, Shou‐Jen Kuo, et al.. (2011). Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study. Evidence-based Complementary and Alternative Medicine. 2011(1). 841564–841564. 14 indexed citations
16.
Ko, Chih‐Jan, Su‐Yu Chien, Chen‐Te Chou, et al.. (2011). Factors Affecting the Prognosis of Small Hepatocellular Carcinoma in Taiwanese Patients Following Hepatic Resection. SHILAP Revista de lepidopterología. 25(9). 485–491. 17 indexed citations
17.
Lai, Hung‐Wen, Su‐Yu Chien, Shou‐Jen Kuo, et al.. (2011). The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: AnIn VitroandIn VivoComparison Study with Herceptin. Evidence-based Complementary and Alternative Medicine. 2012. 1–12. 65 indexed citations
18.
Chen, Yao‐Li, Chih‐Jan Ko, Su‐Yu Chien, et al.. (2010). Tumor size as a prognostic factor in resected small hepatocellular carcinoma: A controversy revisited. Journal of Gastroenterology and Hepatology. 26(5). 851–857. 23 indexed citations
19.
Gau, Churn‐Shiouh, et al.. (2006). Usage of the claim database of national health insurance programme for analysis of cisapride‐erythromycin co‐medication in Taiwan. Pharmacoepidemiology and Drug Safety. 16(1). 86–95. 36 indexed citations
20.
Moore, Marcia M., et al.. (2001). Role of tensile stress and strain in the induction of cell death in experimental vein grafts. Journal of Biomechanics. 34(3). 289–297. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026